Effect of hepatitis C virus coinfection on humoral immune alterations in naïve HIV-infected adults on HAART: A three year follow-up study

Journal of Clinical Immunology

Volumn 25, Issue 3, 2005, Pages 296-302

  Soriano Sarabia, Natalia ^a   Leal, Manuel ^a   Delgado, Carmen ^a   Molina Pinelo, Sonia ^a   De Felipe, Beatriz ^a   Ruiz Mateos, Ezequiel ^a   Sánchez Quijano, Armando ^a   Lissen, Eduardo ^a   Vallejo, Alejandro ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

B cells; CD21; Coinfection; IgG level

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN G; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; B LYMPHOCYTE; COMORBIDITY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INFECTION RISK; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ANTIBODY FORMATION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; B-LYMPHOCYTES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HIV INFECTIONS; HUMANS; HYPERGAMMAGLOBULINEMIA; MALE; RECEPTORS, COMPLEMENT 3D; REGENERATION;

EID: 21244489590     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10875-005-3864-1     Document Type: Article

References (24)

1. Reddy MM, Goetz RR, Gorman JM, Gricco MH, Chess L, Lederman S: Human Immunodeficiency virus type-1 infection of homosexual men is accompanied by a decrease in circulating B cells. J Acquir Immune Defic Syndr 4:428-434, 1991
2. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453-458, 1983
3. Nagase H, Agematsu K, Kitano K, Takamoto M, Okubo Y, Komiyama A, Sugane K: Mechanism of hypergammaglobulinemia by HIV infection: Circulating memory B-cell reduction with plasmacytosis. Clin Immunol 100:250-259, 2001
4. Hunziker L, Recher M, Macpherson AJ, Ciurea A, Freigang S, Hengartner H, Zinkernagel RM: Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol 4:343-349, 2003
5. De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, Grutzmeier S, Sonnerborg A, Chiodi F: Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103:2180-2186, 2004
6. Morris L, Binley JM, Clas BA, Bonhoeffer S, Astill TP, Kost R, Hurley A, Cao Y, Markowitz M, Ho DD, Moore JP: HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 188:233-245, 1998
7. Notermans DW, de Jong JJ, Goudsmit J, Bakker M, Roos MT, Nijholt L, Cremers J, Hellings JA, Danner SA, de Ronde A: Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res Hum Retroviruses 17:1003-1008, 2001
8. Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y: Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: Influence of antiretroviral therapy. Blood 96:4293-4299, 2000
9. Jacobson MA, Khayam-Bashi H, Martin JN, Martin JN, Black D, Ng V: Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr 31:472-477, 2002
10. Zehender G, Meroni L, De Maddalena C, Varchetta S, Monti G, Galli M: Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J Infect Dis 176:1209-1214, 1997
11. Morsica G, Tambussi G, Sitia G, Novati R, Lazzarin A, Lopalco L, Mukenge S, Agnello V, Chung RT, Kaplan LM: Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 94:1138-1139, 1999
12. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
13. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL: Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82:3701-3704, 1993
14. Zignego AL, Brechot C: Extrahepatic manifestations of HCV infection: Facts and controversies. J Hepatol 31:369-376, 1999
15. Franco JM, Rubio A, Martinez-Moya M, Leal M, Merchante E, Sanchez-Quijano A, Lissen E: T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood 99:3702-3706, 2002
16. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM: Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77:2134-2146, 2003
17. Slifka MK, Ahmed R: Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection. Ann NY Acad Sci 797:166-176, 1996
18. Bender BS, Frank MM, Lawley TJ, Smith WJ, Brickman CM, Quinn TC: Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. J Infect Dis 152:409-412, 1985
19. Bender BS, Bohnsack JF, Sourlis SH, Frank MM, Quinn TC: Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. J Clin Invest 79:715-720, 1987
20. Roccatello D, Morsica G, Picciotto G, Cesano G, Ropolo R, Bernardi MT, Cacace G, Cavalli G, Sena LM, Lazzarin A, Piccoli G, Rifai A: Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C viras (HCV) infection. Clin Exp Immunol 110:9-14, 1997
21. Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, Minuk GY: Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat 11:251-256, 2004
22. Gonzalez-Quintela A, Alende MR, Gamallo R, Gonzalez-Gil P, Lopez-Ben S, Tome S, Otero E, Torre JA: Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Hepatogastroenterol 50:2121-2126, 2003
23. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Quaglino D: Changes in antigen expression on B lymphocytes during HIV infection. Pathobiology 66:17-23, 1998
24. Moir S, Malaspina A, Yuexia Li, Chun TW, Lowe T, Adelsberger J, Baseler M, Ehler LA, Liu S, Davey RT Jr, Mican JA, Fauci AS: B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med 192:637-646, 2000